Bristol Myers Squibb news from FierceHealthcare
NewsWill 2009 be Consolidation Year for pharma?
With the giant union between Pfizer and Wyeth en route to being consummated, analysts are now speculating about other major mergers are to follow. Several think this could be the Year of Read more...
| Press ReleasesBristol-Myers Squibb to Present at Goldman Sachs Healthcare CEOs Unscripted ConferenceNEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will present at the Goldman Sachs Healthcare CEOs Unscripted conference Thursday, January 6, 2011, in New York. Lamberto Read more >> Newly Published Investigational Apixaban ADVANCE-3 Study Results Demonstrate Statistical Superiority to Enoxaparin with CoPhase 3 Data Published Today in The New England Journal of Medicine PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today Read more >> Maven Semantic: Toxicity Research DatabaseSearch Over 307,000 People and Over 22,000 Toxicity Research Organisations DUBLIN--(BUSINESS WIRE)-- Maven Semantic (http://www.mavensemantic.com) announces updates to their Toxicity research Read more >> Maven Semantic: Antibodies Research DatabaseSearch Over 472,000 People and Over 35,000 Antibodies Research Organisations DUBLIN--(BUSINESS WIRE)-- Maven Semantic (http://www.mavensemantic.com) announces updates to their Antibodies research Read more >> N. Anthony Coles, M.D. Named to LabCorp® Board of DirectorsBURLINGTON, N.C.--(BUSINESS WIRE)-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH) today announced that N. Anthony Coles, M.D., has been elected to its Board of Directors, effective Read more >> |
